Sheryl Crow, Early Detection, and What Breast Cancer Really Is

Found by a test, not by a symptom

Sheryl Crow was 44 in 2006. She went for her annual mammogram, as she had every year since turning 40, and it found breast cancer.

CBS News reported in 2010 that she had minimally invasive surgery to remove a cancerous lump, then radiation therapy, and had been cancer-free since. The Brem Foundation, a breast health nonprofit, records the same course: early-stage disease, a lumpectomy and radiation.

That year she also opened an imaging center in Los Angeles. Her stated reason was simple. She wanted to encourage women over 40 to get their annual mammogram.

Her own account of the barrier is worth keeping. "A lot of us who are moms are too busy, or we don't want to know. In some instances, we're poorly insured or uninsured."

What was actually found

NCI describes breast cancer as cancer that starts in the breast, when cells there grow without control and form a mass.

It can begin in several places. Most starts in glandular tissue: the ducts that carry milk, or the lobules, the tiny glands that make it. Cancers starting in the ducts are called ductal, and most breast cancers are ductal. Those starting in the lobules are lobular.

Less often it begins in the fibrous and fatty tissue that holds the breast in shape, in the nipple, or in blood and lymph vessels.

The distinction that matters most on a pathology report is different from all of those. When the abnormal cells are still inside a duct or lobule and have not spread into surrounding breast tissue, it is called carcinoma in situ. Once they have crossed out, it is invasive. NCI notes that most breast cancers are invasive.

Our page on breast cancer covers the types, and our page on breast cancer stages covers what the stage numbers describe.

What screening does and does not do

Screening means testing someone with no symptoms. That is the whole idea, and it is why Crow's story is the shape it is.

The U.S. Preventive Services Task Force recommends a mammogram every two years for women aged 40 to 74.

NCI describes other tools too. Breast MRI is often added for women at high risk. Ultrasound is used in some situations. NCI is clear that a clinical breast exam or a breast self-exam on its own is not an adequate screening test.

Screening also has costs. False positives are the most common: an abnormal result that turns out to be nothing, after more imaging and sometimes a biopsy. Our page on the benefits and harms of screening sets out both sides, and our guide to mammograms covers the appointment itself.

When to get checked

Two tracks, and they do not substitute for each other.

Screening runs on a schedule. Every two years from 40 to 74 for women at average risk. Earlier or more often for those at higher risk, which is a conversation to have rather than a rule to look up.

Symptoms run on their own clock. NCI says to check with a doctor about:

• A lump in or near the breast, or under the arm.
• A thick or firm area in either place.
• A change in the size or shape of a breast.
• Fluid or discharge from the nipple that is not breast milk.
• A nipple that changes shape, flattens, or points differently.
• Scaly or swollen skin, redness or darkening, or itching on the breast, nipple or areola.

A normal mammogram six months ago does not cancel a new lump today. Symptoms get looked at when they appear.

The group picture

SEER figures describe the United States population, not any individual.

Five-year relative survival for female breast cancer is 91.9 percent for cases from 2016 to 2022. By stage it is 100.0 percent while the cancer is confined to the breast, 87.5 percent once it has reached nearby lymph nodes, and 33.8 percent once it has spread further.

Sixty-four percent are found at that first stage. That share is the main reason the overall number sits where it does, and it is what a screening program is trying to move.

An estimated 321,910 new cases and 42,140 deaths are projected for 2026. The median age at diagnosis is 64.

What this does not mean

It does not mean a mammogram guarantees an early diagnosis. Some cancers are missed, and some grow between scheduled tests. Dense breast tissue makes both more likely.

It does not mean every early cancer needs the same treatment. Surgery, radiation, hormone therapy and chemotherapy are combined differently depending on the type, the stage and the receptor results.

It does not mean an outcome. Crow's course was hers. Stage, subtype and general health shape each person's separately.

What does carry across is the mechanism. She felt fine. The test found it anyway. That is the only thing screening is for, and it is why the appointment matters most when nothing seems wrong.

Sources

• CBS News, Sheryl Crow Opens Breast Cancer Center in Los Angeles — https://www.cbsnews.com/news/sheryl-crow-opens-breast-cancer-center-in-los-angeles/
• Brem Foundation, At 44, Sheryl Crow Discovered Breast Cancer During Annual Mammogram — https://www.bremfoundation.org/the-brem-blog/cheryl-crow-early-detection-advocate
• NCI, What Is Breast Cancer? — https://www.cancer.gov/types/breast/what-is-breast-cancer
• NCI, Breast Cancer Signs and Symptoms — https://www.cancer.gov/types/breast/symptoms
• SEER Cancer Stat Facts, Female Breast Cancer — https://seer.cancer.gov/statfacts/html/breast.html
• USPSTF, Breast Cancer: Screening — https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.